The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs

From Nature, 12 February 2026: What do tennis star Serena Williams, television personality Oprah Winfrey and actors Kathy Bates and Whoopi Goldberg have in common? They are some of the many celebrities who have spoken publicly about using GLP-1 receptor agonists to lose weight. Glucagon-like peptide-1 (GLP-1) receptor agonists — which bind to GLP-1 receptors Continue reading The ‘astounding’ rise of semaglutide — and what’s next for weight-loss drugs

‘Hollywood skinny jab’: what do we know about anti-obesity drugs such as Ozempic in Australia?

From the Guardian, 8 April 2023: Dr Kathryn Williams has had patients cry when they go on anti-obesity drugs. “[They] say, ‘oh my God, this is the first time I haven’t felt hungry,’” says Williams, an endocrinologist at the University of Sydney, “because hunger is just something they have to live with every single day.” Continue reading ‘Hollywood skinny jab’: what do we know about anti-obesity drugs such as Ozempic in Australia?